|
Aug 10
|
Hims & Hers Shares Plunge. Is This a Buying Opportunity or Should Investors Run for the Hills?
|
|
Aug 9
|
Why Hims & Hers Stock Sank This Week
|
|
Aug 8
|
Capital Compounders for Investors
|
|
Aug 8
|
Hims Stock Gets Booted Off IBD 50 While Other Volatile Names Hang On
|
|
Aug 8
|
MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Hospital Information System Quadrant Report 2025
|
|
Aug 7
|
Hims & Hers Redefines Virtual Care With Integrated Tech Platforms
|
|
Aug 7
|
2 Surging Stocks to Research Further and 1 We Turn Down
|
|
Aug 6
|
Novo Nordisk Slumps As 'Unlawful' Knockoffs Pressure Wegovy, Ozempic
|
|
Aug 6
|
Cash pay is 'going to constitute a major part of the Wegovy business': Novo Nordisk CFO
|
|
Aug 6
|
Hims & Hers (HIMS) Falls 12.36% on Weaker Revenues
|
|
Aug 6
|
These Are the Smartest Growth Stocks to Invest $1,000 in Today
|
|
Aug 6
|
AI and GLP-1s were the hot post-pandemic trades, but only one is thriving
|
|
Aug 5
|
Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer
|
|
Aug 5
|
These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More
|
|
Aug 5
|
Hims & Hers Had a Tough Quarter. Weight-Loss Drugs Are Only One Problem.
|
|
Aug 5
|
HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down
|
|
Aug 5
|
Why Hims & Hers Health Stock Just Dropped
|
|
Aug 5
|
Hims & Hers Health, DuPont, Gartner: Trending Tickers
|
|
Aug 5
|
Hims & Hers stock slides 5% after second quarter revenue misses forecasts
|
|
Aug 5
|
Hims & Hers Stock Nosedives After Q2 Revenue Miss Despite 73% Growth
|